Cargando…
Mass Spectrometry in Cerebrospinal Fluid Uncovers Association of Glycolysis Biomarkers with Alzheimer’s Disease in a Large Clinical Sample
BACKGROUND: Alzheimer’s disease (AD) is a complex heterogenous neurodegenerative disorder, characterized by multiple pathophysiologies, including disruptions in brain metabolism. Defining markers for patient stratification across these pathophysiologies is an important step towards personalized trea...
Autores principales: | de Geus, Matthijs B., Leslie, Shannon N., Lam, TuKiet, Wang, Weiwei, Kivisakk, Pia, Nairn, Angus C., Arnold, Steven E., Carlyle, Becky C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350182/ https://www.ncbi.nlm.nih.gov/pubmed/37461556 http://dx.doi.org/10.21203/rs.3.rs-3073597/v1 |
Ejemplares similares
-
Enhancing Classification of liquid chromatography mass spectrometry data with Batch Effect Removal Neural Networks (BERNN)
por: Droit, Arnaud, et al.
Publicado: (2023) -
Development of Targeted Mass Spectrometry-Based Approaches for Quantitation of Proteins Enriched in the Postsynaptic Density (PSD)
por: Wilson, Rashaun S., et al.
Publicado: (2019) -
Cerebrospinal fluid proteome evaluation in major depressive disorder by mass spectrometry
por: Franzen, Avery D., et al.
Publicado: (2020) -
Evaluation of the Phosphoproteome of Mouse Alpha 4/Beta 2-Containing Nicotinic Acetylcholine Receptors In Vitro and In Vivo
por: Miller, Megan B., et al.
Publicado: (2018) -
Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
por: Leslie, Shannon N., et al.
Publicado: (2021)